Clinical Trials Browser

Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT06644625 2026-01-20

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Recruiting

1,665 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Phase NA Recruiting

200 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT03616483 2025-11-10

The Indiana Myeloma Registry

Recruiting

2,500 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias, Plasmacytoma

NCT04114084 2025-11-10

Sleep Apnea in Patients With MGUS and MM

Recruiting

200 enrolled

Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT06895291 2025-03-30

ONCO-MRI

Recruiting

1,000 enrolled

LymphoidPlasma cell

Smoldering Multiple Myeloma, Lymphoma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT06690593 2024-12-27

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

Recruiting

2,990 enrolled

Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT04731844 2024-07-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Phase 2 Recruiting

40 enrolled

GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

NCT05965115 2023-08-01

CHAPERONE

Recruiting

10,000 enrolled

Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT05283993 2022-04-25

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting

2,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, POEMS Syndrome

Clinical Trials

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

ProDigALIty

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

TRANSFORMM

LINKER-MGUS1

B-SCR-MM

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

The Indiana Myeloma Registry

Sleep Apnea in Patients With MGUS and MM

ONCO-MRI

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

CHAPERONE

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH